Robert J Dorosky1, Jeremy E Schreier2, Stephanie L Lola3

  • 1Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Robert.Dorosky@fda.hhs.gov.

AMB Express
|January 20, 2024
PubMed
概括

研究人员开发了新的纳米体试剂,用于活生物疗法产品 (LBP) 功效测试. 这些特定的纳米体可以在复杂的混合物中区分和量化细菌菌株,推进LBP测试和临床研究.